Chairman
Fortrea Holdings Inc. (FTRE)Board Member
Fortrea Holdings Inc. (FTRE)Equibles does not estimate personal net worth.
Get an email with a short summary when Fortrea Holdings Inc. publishes a filing, an earnings call transcript or a press release.
Get FTRE alertsThomas Pike is recorded as Chairman and CEO at Fortrea Holdings Inc. (FTRE) since July 3, 2023 and Board Member at Fortrea Holdings Inc. (FTRE) since June 29, 2023. The newest filing on record that lists Thomas Pike as CEO at Fortrea Holdings Inc. (FTRE) is dated April 27, 2026. Fortrea Holdings Inc. reported in an 8-K filed July 3, 2023 that Thomas Pike was appointed Chairman of our board of directors. Fortrea Holdings Inc. reported in an 8-K filed July 3, 2023 that Thomas Pike was appointed Chief Executive Officer. Fortrea Holdings Inc. reported in an 8-K filed July 3, 2023 that Thomas Pike was appointed director, effective June 29, 2023. The proxy statement of Fortrea Holdings Inc. reports total compensation of $7,791,722 for Thomas Pike in fiscal 2025, including a base salary of $465,385. Disclosed compensation is on record for 3 fiscal years. Thomas Pike has spoken on 2 earnings calls across 1 company, most recently for Fortrea Holdings Inc. on May 13, 2024. Fortrea Holdings Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Fortrea Holdings Inc. includes Anshul Thakral (CEO and Board Member), Peter M. Neupert (CEO and Board Member), Jason F. Knoblauch (CFO) and 7 others.
“Mr. Pike will serve as Chairman of our board of directors.”
“Thomas Pike, who served as President and Chief Executive Officer of the Drug Development, Clinical Development and Commercialization Services business unit of Labcorp since January 2023, will serve as our Chief Executive Officer bringing his 30+ years of industry experience to the job.”
“I appreciate everyone joining this morning. We have a good deal of ground to cover, so let's get into it. In summary, the environment for and reception of Fortrea's clinical services offerings remains strong and is good enough to meet our growth ambitions.”
“This is the second earnings call we have done as a public company and the first full quarter where the new management team has been running the newly spun out company.”
2023-07-03–present
2023-07-03–present
Last confirmed April 27, 2026
2023-06-29–present
Start not stated–2025-05-13
Start not stated–2025-05-13
Biotechnology · Healthcare
Chairman, CEO, Board Member
2023-06-29–present
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Fortrea Holdings Inc. (FTRE) | Former Chief Executive Officer | $465,385 | $7,791,722 |
| 2024 | Fortrea Holdings Inc. (FTRE) | Chief Executive Officer | $1,108,461 | $1,713,906 |
| 2023 | Fortrea Holdings Inc. (FTRE) | Chief Executive Officer | $1,078,846 | $26,320,395 |
